Dietrich Stephan, Ph.D. Founder & CEO of NeuBase Therapeutics (NASDAQ: NBSE) – Aug. 26, 2020
- Published Sep 10, 2020
- Biotech & Healthcare
- Neubase Therapeutics
[social_share_button themes='theme8']
YOUR GUIDE TO STAYING INFORMED IN THE MARKETS
Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!